Cargando…

Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus

Clear cell renal cell carcinoma (ccRCC) with venous tumor thrombus (VTT) is associated with poor prognosis. Our integrative analyses of transcriptome and proteome reveal distinctive molecular features of ccRCC with VTT, and yield the development of a prognostic classifier to facilitate ccRCC molecul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Xiaolei, Pang, Qingyang, Nian, Xinwen, Jiang, Aimin, Shi, Haoqing, Liu, Wenqiang, Gan, Xinxin, Gao, Yisha, Yang, Yiren, Ji, Jin, Tan, Xiaojie, Xiao, Chengwu, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276054/ https://www.ncbi.nlm.nih.gov/pubmed/37328520 http://dx.doi.org/10.1038/s41598-023-36978-5

Ejemplares similares

A morphology-based nephrometry score to predict pathological upstaging to T3 renal cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2023)

Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics
por: Yang, Yiren, et al.
Publicado: (2023)

Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

Proteomic analysis reveals distinctive protein expression patterns of thrombus in clear cell renal cell carcinoma
por: Zhou, Juntuo, et al.
Publicado: (2020)

Clear Cell Renal Cell Carcinoma with a Ureteral Thrombus
por: John, Jeff, et al.
Publicado: (2018)

Identification of Long Noncoding RNA APOC1P1 as an Oncogene in Clear Cell Renal Cell Carcinoma
por: Sun, Chong, et al.
Publicado: (2019)

Development and validation of a prognostic model incorporating tumor thrombus grading for nonmetastatic clear cell renal cell carcinoma with tumor thrombus: A multicohort study
por: Qu, Le, et al.
Publicado: (2023)

Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus
por: Wang, Xiang-Ming, et al.
Publicado: (2020)

Characterizing Tumor Thrombus Arising from Non–Clear Cell Renal Cell Carcinoma
por: Rabinowitz, Matthew J., et al.
Publicado: (2022)

Decoding the multicellular ecosystem of vena caval tumor thrombus in clear cell renal cell carcinoma by single-cell RNA sequencing
por: Shi, Yue, et al.
Publicado: (2022)

DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma
por: Bao, Yewei, et al.
Publicado: (2021)

Clear cell sarcoma of the kidney with inferior vena cava thrombus: a case report
por: Doya, Leen Jamel, et al.
Publicado: (2022)

Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma
por: Gao, Yiren, et al.
Publicado: (2022)

Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis
por: Jiang, Aimin, et al.
Publicado: (2022)

Proteomics Characterization of Clear Cell Renal Cell Carcinoma
por: Miranda-Poma, Jesús, et al.
Publicado: (2023)

ENO2 as a Biomarker Regulating Energy Metabolism to Promote Tumor Progression in Clear Cell Renal Cell Carcinoma
por: Shi, Jian, et al.
Publicado: (2023)

Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma
por: Roldán, Fiorella L., et al.
Publicado: (2021)

A case of clear cell renal cell carcinoma with vena cava thrombus responding to presurgical avelumab, and axitinib
por: Suzuki, Issei, et al.
Publicado: (2021)

MRI-Based Grading of Clear Cell Renal Cell Carcinoma Using a Machine Learning Classifier
por: Chen, Xin-Yuan, et al.
Publicado: (2021)

Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
por: Gu, Yufeng, et al.
Publicado: (2023)

Characterizing the molecular heterogeneity of clear cell renal cell carcinoma subgroups classified by miRNA expression profile
por: Shen, Tao, et al.
Publicado: (2022)

Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
por: Tan, Diaoyi, et al.
Publicado: (2023)

Identification of Potential Serum Proteomic Biomarkers for Clear Cell Renal Cell Carcinoma
por: Yang, Juan, et al.
Publicado: (2014)

Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma
por: Fan, ZhiXiang, et al.
Publicado: (2022)

The Weight-Based Feature Selection (WBFS) Algorithm Classifies Lung Cancer Subtypes Using Proteomic Data
por: Wang, Yangyang, et al.
Publicado: (2023)

As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner
por: Miao, Daojia, et al.
Publicado: (2022)

Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma
por: Liu, Yifei, et al.
Publicado: (2021)

Imaging tumour thrombus of clear cell renal cell carcinoma: FDG PET or PSMA PET? Direct in vivo comparison of two technologies
por: Saadat, Seyedehpariya, et al.
Publicado: (2017)

An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma
por: Gossage, Lucy, et al.
Publicado: (2014)

Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression
por: Gao, Yuqian, et al.
Publicado: (2020)

Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma
por: Tang, Wenbin, et al.
Publicado: (2023)

Magneto-Elastic μ-Vibrator for Smashing Thrombus
por: Li, Wei, et al.
Publicado: (2019)

N6‐methyladenosine‐modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway
por: Miao, Daojia, et al.
Publicado: (2023)

Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers
por: Dakna, Mohammed, et al.
Publicado: (2010)

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)
por: Stewart, Grant D., et al.
Publicado: (2022)

The risk factors of thrombus formation and the effect of catheter ablation on repetitive thrombus formation in patients with atrial fibrillation: a single center retrospective study in China
por: Liu, Huiyu, et al.
Publicado: (2023)

Genomic Landscape of Chinese Clear Cell Renal Cell Carcinoma Patients With Venous Tumor Thrombus Identifies Chromosome 9 and 14 Deletions and Related Immunosuppressive Microenvironment
por: Niu, Shaoxi, et al.
Publicado: (2021)

The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tr4l6urj7tvuvh79bma5td4ec8